BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15283822)

  • 1. Buprenorphine blocks withdrawal in morphine-dependent rat pups.
    Stoller DC; Smith FL
    Paediatr Anaesth; 2004 Aug; 14(8):642-9. PubMed ID: 15283822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 24-h access I.V. self-administration schedule of morphine reinforcement and the estimation of recidivism: Pharmacological modification by arecoline.
    Buccafusco JJ; Bain JN
    Neuroscience; 2007 Nov; 149(3):487-98. PubMed ID: 17916413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine substitution ameliorates spontaneous withdrawal in fentanyl-dependent rat pups.
    Lohmann AB; Smith FL
    Pediatr Res; 2001 Jan; 49(1):50-5. PubMed ID: 11134491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
    Oifa S; Sydoruk T; White I; Ekstein MP; Marouani N; Chazan S; Skornick Y; Weinbroum AA
    Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A method for the quantitative assessment of the withdrawal syndrome in morphine-dependent rats].
    Sudakov SK; Borisova EV; Rusakov DIu
    Eksp Klin Farmakol; 1994; 57(2):60-3. PubMed ID: 8205055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in urination/defecation, auditory startle response, and startle-induced ultrasonic vocalizations in rats undergoing morphine withdrawal: similarities and differences between acute and chronic dependence.
    Kalinichev M; Holtzman SG
    J Pharmacol Exp Ther; 2003 Feb; 304(2):603-9. PubMed ID: 12538812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
    Holtzman SG
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine withdrawal modifies antinociceptive effects of acute morphine in rats.
    Dong Z; Mao R; Han H; Cao J; Xu L
    Biochem Biophys Res Commun; 2006 Jul; 346(2):578-82. PubMed ID: 16762316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of combined administration of intrathecal morphine with subcutaneous morphine or buprenorphine.
    Chen LH; Nemirovsky A; Gong QY
    Acta Pharmacol Sin; 2000 Aug; 21(8):685-9. PubMed ID: 11501175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mirtazapine, a noradrenergic and specific serotonergic antidepressant, attenuates morphine dependence and withdrawal in Sprague-Dawley rats.
    Kang L; Wang D; Li B; Hu M; Zhang P; Li J
    Am J Drug Alcohol Abuse; 2008; 34(5):541-52. PubMed ID: 18618337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
    Dunbar SA; Karamian I; Zhang J
    Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender- and morphine dose-linked expression of spontaneous somatic opiate withdrawal in mice.
    Papaleo F; Contarino A
    Behav Brain Res; 2006 Jun; 170(1):110-8. PubMed ID: 16580078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early neonatal experience of Long-Evans rats results in long-lasting changes in morphine tolerance and dependence.
    Kalinichev M; Easterling KW; Holtzman SG
    Psychopharmacology (Berl); 2001 Sep; 157(3):305-12. PubMed ID: 11605087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.
    Lee PH; McNutt RW; Chang KJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):883-7. PubMed ID: 8246163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of neonatal rat fentanyl tolerance and dependence.
    Thornton SR; Smith FL
    J Pharmacol Exp Ther; 1997 Apr; 281(1):514-21. PubMed ID: 9103539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S; Göktalay G; Millington WR
    J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The withdrawal syndrome and lipid peroxidation during the chronic administration of narcotic analgesics to rats].
    Konstantinopol'skiĭ MA; Pirozhkov SV; Solov'eva AG; Panchenko LF; Barkov NK
    Eksp Klin Farmakol; 1992; 55(1):21-4. PubMed ID: 1363943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single opioid administration modifies gonadal steroids in both the CNS and plasma of male rats.
    Ceccarelli I; De Padova AM; Fiorenzani P; Massafra C; Aloisi AM
    Neuroscience; 2006 Jul; 140(3):929-37. PubMed ID: 16580783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans.
    Schuh KJ; Walsh SL; Bigelow GE; Preston KL; Stitzer ML
    J Pharmacol Exp Ther; 1996 Aug; 278(2):836-46. PubMed ID: 8768738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.